IMR Press / EJGO / Volume 43 / Issue 1 / DOI: 10.31083/j.ejgo4301016
Open Access Communication
PARP inhibition in ovarian cancer: what is still missing?
Show Less
1 Ludwig Institute for Cancer Research, Bâtiment AGORA, 1005 Lausanne, Switzerland
2 Department of Gynecology, CHUV-Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
3 Department of Oncology, Immuno-Oncology Service, CHUV-Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland

Academic Editor: Enrique Hernandez

Eur. J. Gynaecol. Oncol. 2022, 43(1), 143–145; https://doi.org/10.31083/j.ejgo4301016
Submitted: 11 October 2021 | Revised: 16 November 2021 | Accepted: 19 November 2021 | Published: 15 February 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Share
Back to top